{
 "name": "長聖",
 "slug": "tw-6712",
 "aliases": [
  "長聖國際生技股份有限公司",
  "Ever Supreme",
  "6712"
 ],
 "ticker": "6712",
 "industry": "生技醫療業",
 "website": "www.ever-supreme.com.tw",
 "summary": "長聖（6712）是上櫃的生技醫療類股公司，2016 年成立，2021 年上櫃。基本資料取自臺灣證券交易所／證券櫃檯買賣中心公開資料；重大訊息見 https://drugnews.com.tw/filings/ 。",
 "facts": [
  {
   "claim": "公司全名",
   "value": "長聖國際生技股份有限公司",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "英文簡稱",
   "value": "Ever Supreme",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "產業類別",
   "value": "生技醫療業",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "掛牌市場",
   "value": "證券櫃檯買賣中心上櫃",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "上櫃日期",
   "value": "2021-01-08",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "成立日期",
   "value": "2016-12-06",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "董事長",
   "value": "劉銖淇",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "總經理",
   "value": "黃文良",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "實收資本額",
   "value": 1004888610,
   "unit": "新台幣元",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "簽證會計師事務所",
   "value": "安永聯合會計師事務所",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "公司網址",
   "value": "www.ever-supreme.com.tw",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "月營收（2026-09）",
   "value": 110469,
   "unit": "新台幣千元",
   "as_of": "2026-10-17",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap05_O",
   "note": "原檔二手來源不在白名單；回查官方115年09月營收申報，claim/value/unit/as_of與原值一致並保留。出表日期1151017；僅更正source及補note。"
  },
  {
   "claim": "月營收年增率（2026-09）",
   "value": 21.26,
   "unit": "%",
   "as_of": "2026-10-17",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap05_O",
   "note": "原檔二手來源不在白名單；回查官方115年09月營收申報，claim/value/unit/as_of與原值一致並保留。出表日期1151017；僅更正source及補note。"
  },
  {
   "claim": "累計營收年增率（2026 年 1 月至 09 月）",
   "value": 17.64,
   "unit": "%",
   "as_of": "2026-10-17",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap05_O",
   "note": "原檔二手來源不在白名單；回查官方115年09月營收申報，claim/value/unit/as_of與原值一致並保留。出表日期1151017；僅更正source及補note。"
  },
  {
   "claim": "管線：ADCV01（自體樹突細胞）",
   "value": "原發性多形性膠質母細胞瘤｜二期臨床招募中｜台灣",
   "unit": "",
   "as_of": "2026-09-24",
   "source": "https://clinicaltrials.gov/study/NCT04115761",
   "note": "NCT04115761；as_of為試驗登錄最後更新公開日；地區指登錄試驗地點。"
  },
  {
   "claim": "管線：UMSC01（異體臍帶間質幹細胞）",
   "value": "急性ST節段上升心肌梗塞｜二期臨床招募中｜台灣",
   "unit": "",
   "as_of": "2026-09-23",
   "source": "https://clinicaltrials.gov/study/NCT06147986",
   "note": "NCT06147986；as_of為試驗登錄最後更新公開日；地區指登錄試驗地點。"
  },
  {
   "claim": "管線：UMSC01（異體臍帶間質幹細胞）",
   "value": "急性缺血性腦中風｜一期臨床已完成｜台灣",
   "unit": "",
   "as_of": "2026-09-23",
   "source": "https://clinicaltrials.gov/study/NCT04434768",
   "note": "NCT04434768；as_of為試驗登錄最後更新公開日；地區指登錄試驗地點。"
  },
  {
   "claim": "管線：UMSC01（異體臍帶間質幹細胞）",
   "value": "多發性硬化症｜一期／二期臨床招募中｜台灣",
   "unit": "",
   "as_of": "2025-08-07",
   "source": "https://clinicaltrials.gov/study/NCT05532943",
   "note": "NCT05532943；as_of為試驗登錄最後更新公開日；地區指登錄試驗地點。"
  },
  {
   "claim": "管線：UMSC01（異體臍帶間質幹細胞）",
   "value": "COVID-19感染｜一期／二期臨床進行中，已停止招募｜台灣",
   "unit": "",
   "as_of": "2026-09-23",
   "source": "https://clinicaltrials.gov/study/NCT05501418",
   "note": "NCT05501418；as_of為試驗登錄最後更新公開日；地區指登錄試驗地點。"
  },
  {
   "claim": "管線：CAR001（嵌合抗原受體Gamma-Delta T細胞）",
   "value": "復發／難治性實體腫瘤｜一期劑量遞增完成，TFDA同意開啟二a期收案｜台灣",
   "unit": "",
   "as_of": "2026-06-28",
   "source": "https://mopsov.twse.com.tw/mops/web/ajax_t05st01?firstin=true&year=115&month=all&step=2&seq_no=1&spoke_time=154147&spoke_date=20260628&co_id=6712&TYPEK=otc",
   "note": "發言日期：2026-06-28；主旨：本公司新藥CAR001第一期臨床試驗完成，並獲衛生福利部食品藥物管理署(TFDA)同意開啟Phase Ⅱa臨床試驗收案；NCT06150885；FDA/TFDA核准計畫不代表已取得藥證。"
  },
  {
   "claim": "催化劑：UMSC01",
   "value": "心肌梗塞二期試驗預估完成｜2027-06-24｜已公告",
   "unit": "",
   "as_of": "2026-09-23",
   "source": "https://clinicaltrials.gov/study/NCT06147986",
   "note": "NCT06147986；試驗登錄ESTIMATED日期，非主管機關核准或完成承諾。"
  },
  {
   "claim": "催化劑：CAR001",
   "value": "一期／二a期試驗預估主要完成｜2027-06-30｜已公告",
   "unit": "",
   "as_of": "2026-09-09",
   "source": "https://clinicaltrials.gov/study/NCT06150885",
   "note": "NCT06150885；試驗登錄ESTIMATED日期，非主管機關核准或完成承諾。"
  },
  {
   "claim": "催化劑：ADCV01",
   "value": "GBM二期試驗預估完成｜2027-12-30｜已公告",
   "unit": "",
   "as_of": "2026-09-24",
   "source": "https://clinicaltrials.gov/study/NCT04115761",
   "note": "NCT04115761；試驗登錄ESTIMATED日期，非主管機關核准或完成承諾。"
  },
  {
   "claim": "催化劑：UMSC01",
   "value": "COVID-19一期／二期試驗預估完成｜2027-12-31｜已公告",
   "unit": "",
   "as_of": "2026-09-23",
   "source": "https://clinicaltrials.gov/study/NCT05501418",
   "note": "NCT05501418；試驗登錄ESTIMATED日期，非主管機關核准或完成承諾。"
  },
  {
   "claim": "授權合作：UMSC01",
   "value": "美國合資公司（與Minerva Scientifics, Corp.、Axeon Research LLC共同設立）｜台灣以外全球｜2024-01-19",
   "unit": "",
   "as_of": "2024-01-19",
   "source": "https://mopsov.twse.com.tw/mops/web/ajax_t05st01?firstin=true&year=113&month=all&step=2&seq_no=1&spoke_time=162457&spoke_date=20240119&co_id=6712&TYPEK=otc",
   "note": "發言日期：2024-01-19；主旨：公告本公司董事會決議與Minerva Scientifics, Corp.及Axeon Research LLC 簽訂專屬再授權、移轉暨合資契約；專屬再授權、移轉暨合資契約；公告未揭合資公司名稱。"
  },
  {
   "claim": "簽約金：UMSC01",
   "value": 3000000,
   "unit": "美元",
   "as_of": "2024-01-19",
   "source": "https://mopsov.twse.com.tw/mops/web/ajax_t05st01?firstin=true&year=113&month=all&step=2&seq_no=1&spoke_time=162457&spoke_date=20240119&co_id=6712&TYPEK=otc",
   "note": "發言日期：2024-01-19；主旨：公告本公司董事會決議與Minerva Scientifics, Corp.及Axeon Research LLC 簽訂專屬再授權、移轉暨合資契約；合約應收簽約金；本筆不代表公告日已收款。"
  }
 ],
 "responses": [],
 "provided_by": "public_sources",
 "verified_by": "Drugnews｜藥時事",
 "verified_at": "2026-10-22",
 "disclosure": "Drugnews 依公開來源（公司公告、公開資訊觀測站、試驗登錄、主管機關文件）整理，於 verified_at 逐條核對來源；未經公司審閱。",
 "url": "https://drugnews.com.tw/companies/tw-6712.json",
 "generated_at": "2026-10-23T01:06:05.573Z"
}